Skip to main content

Table 4 The correlations between SLC39A6 protein expression and clinicopathologic characteristics in Kazakh and Han ethnic

From: SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma

Variables

SLC39A6 expression in Han ethnic

SLC39A6 expression in Kazakh ethnic

Total cases

Low n (%)

High n (%)

P value

Total cases

Low n (%)

High n (%)

P value

Gender

   

0.863

   

0.621

 Male

107

35 (32.71)

72 (67.29)

 

53

12 (22.64)

41 (77.36)

 

 Female

35

12 (34.29)

23 (65.71)

 

33

6 (18.18)

27 (81.82)

 

Age (years)

   

0.254

   

0.113

 ≤60

57

22 (38.60)

35 (61.40)

 

53

14 (26.42)

39 (73.58)

 

 >60

85

25 (29.41)

60 (70.59)

 

33

4 (12.12)

29 (87.88)

 

Differentiationa

   

0.018

   

0.003

 Well

39

20 (51.28)

19 (48.72)

 

21

10 (47.62)

11 (52.38)

 

 Moderate

74

19 (25.68)

55 (74.32)

 

53

6 (11.32)

47 (88.68)

 

 Poor

29

8 (27.59)

21 (72.41)

 

12

2 (16.67)

10 (83.33)

 

Lymph node metastasis

   

0.050

   

0.690

 No

93

36 (38.71)

57 (61.29)

 

37

7 (18.92)

30 (81.08)

 

 Yes

49

11 (22.45)

38 (77.55)

 

49

11 (22.45)

38 (77.55)

 

TNM stage

   

0.276

   

0.026

 I + II

94

34 (36.17)

60 (63.83)

 

53

7 (13.21)

46 (86.79)

 

 III + IV

48

13 (27.01)

35 (72.99)

 

33

11 (33.33)

22 (66.67)

 
  1. P < 0.05 indicates a significant association among the variables
  2. aWell-differentiation vs. moderate differentiation + poor differentiation